Durgical
EN
Open the app

Breast cancer screening in Colombia

  • Routine care

Breast cancer is the most common cancer in women worldwide. Found small, it is usually curable; finding it small is the whole point of screening.

Updated

See it in 3D: Mammary gland lobes · Lactiferous ducts · Nipple

What it is

Screening looks for breast cancer in women without symptoms. In Colombia, Resolución 3280 de 2018 (Ruta de Promoción y Mantenimiento de la Salud) sets a clinical breast examination every year from 40 and a two-view mammogram every two years from 50 to 69. Results are reported in BI-RADS categories: normal or benign results continue the schedule, probably benign findings follow the breast cancer care route, and suspicious ones lead to an active search for the woman and a priority biopsy. Women with hereditary or family risk factors are referred to the breast cancer care route. Self-examination is taught as awareness of warning signs, not as a substitute for screening. A woman with symptoms is not screened: she gets a diagnostic workup at any age. How intensely to screen depends on risk. Risk models estimate it from the history: the Gail model uses age, age at first period and first birth, previous breast biopsies (especially atypical hyperplasia), race or ethnicity and first-degree relatives with breast cancer, and gives a five-year and lifetime risk; the Tyrer–Cuzick model adds a detailed family tree, hormonal factors and breast density, so it suits women with a family history better. High risk means a known BRCA1, BRCA2 or other high-penetrance variant (or an untested first-degree relative of a carrier), chest radiation between about 10 and 30 years of age (for example for Hodgkin lymphoma), or an estimated lifetime risk of about 20% or more. These women start earlier, usually from about 25 to 30, with a yearly breast MRI added to mammography, because MRI is the most sensitive test and is not blinded by dense tissue; it is not used for average-risk women because it brings many false alarms and biopsies.

What it looks for

  • From 40: clinical breast examination every year (Res. 3280 de 2018).
  • From 50 to 69: two-view mammogram every two years; with a normal or benign result (BI-RADS 1 or 2), continue every two years until 69.
  • BI-RADS 3: further diagnostic or follow-up steps as the breast cancer care route defines.
  • BI-RADS 4A, 4B, 4C or 5: actively find the woman, give a priority results appointment and order a biopsy.
  • The history looks for hereditary, family and personal risk factors; if present, refer to the breast cancer care route.
  • Warning signs to teach: a lump in the breast or armpit, skin thickening or retraction, colour change, new nipple retraction, new asymmetry, ulcers, and spontaneous or bloody nipple discharge.
  • Risk models (Gail, Tyrer–Cuzick) turn the history into an estimated risk; the Gail model does not suit women with a BRCA variant, previous chest radiation or a strong family history, where Tyrer–Cuzick or a genetic assessment fits better.
  • High risk (BRCA1, BRCA2 or another high-penetrance variant, chest radiation before about 30, or lifetime risk about 20% or more): yearly breast MRI plus mammography, starting earlier, planned by specialists.

How it is done

  1. Ask about risk factors: family history of breast or ovarian cancer, known BRCA variant, chest radiation when young, previous breast disease.
  2. Explain the purpose, benefits and possible discomfort of each test, and why she must come back for the result.
  3. From 40, examine both breasts and armpits in a private, calm setting, letting her say if anything hurts.
  4. From 50 to 69, order a two-view mammogram every two years; the result should be read and reported within 15 calendar days.
  5. Deliver every result and act by BI-RADS category; for 4 or 5, contact her actively and order a biopsy.
  6. Record the date, test and result, give her a card with the next appointment, and teach the warning signs.

BI-RADS categories that are easy to confuse

CategoryMeaningWhat happens next
0Incomplete: the image cannot be judged yetMore views or ultrasound before any conclusion
1 and 2Normal, or a clearly benign findingBack to routine screening every two years
3Probably benignShort-interval follow-up or diagnostic steps per the breast cancer route; not a biopsy by default
4A, 4B, 4CSuspicious, from low to high suspicionBiopsy, with priority
5Highly suggestive of cancerBiopsy, with priority, and fast referral
6Cancer already proven by biopsyTreatment planning

Common mistakes

  • Screening is for women without symptoms. A woman of any age with a lump, skin change or nipple discharge gets a diagnostic workup now, not at her next screening date.
  • Under about 40, or in pregnancy and breastfeeding, ultrasound is the first imaging test for a lump.
  • Dense breasts hide cancers on mammography; a normal mammogram does not clear a palpable lump, which needs examination, imaging and, if in doubt, a biopsy.
  • Delay → a larger tumour → spread to the axillary nodes → harder treatment and lower survival; in Latin America many cancers are still found at advanced stages.
  • Women at high risk (BRCA carriers, chest radiation when young) need earlier and more intensive screening planned by specialists, often with MRI.

Next step / When to refer

  • BI-RADS 4 or 5: priority biopsy (usually core needle) and referral to the breast cancer care route.
  • Any palpable lump, skin retraction, new nipple inversion or bloody discharge: diagnostic imaging and referral, at any age.
  • Hereditary or family risk on history: refer to the breast cancer care route and to genetic counselling.
  • After 69: decide with the woman, by her health and preferences, whether to continue.
  • High-risk woman (BRCA variant, chest radiation when young, very high estimated risk): refer to a breast specialist or high-risk clinic for earlier screening with yearly MRI and mammography.

Common traps

  • Monthly self-examination can replace mammography: Res. 3280 teaches it as awareness of warning signs and states plainly that it does not replace the screening tests.
  • A palpable lump with a normal mammogram is reassuring: some cancers do not show on mammography, especially in dense breasts, so the lump needs ultrasound and often a biopsy.
  • BI-RADS 3 means probably cancer: it means probably benign and is followed up; categories 4 and 5 are the ones that need a biopsy.
  • A 35-year-old with a lump is too young for breast cancer: screening ages are for women without symptoms, and any woman with symptoms gets a diagnostic workup.
  • Breast MRI is the best test, so every woman should be screened with it: MRI is the most sensitive test but gives many false positives and biopsies; it is kept for high-risk women (BRCA, chest radiation when young, lifetime risk about 20% or more), added to mammography.

Test yourself

Think of the answer, then tap the question to see it.

A 52-year-old with no symptoms asks what breast screening she needs in Colombia. What does Res. 3280 set?

A clinical breast examination every year and a two-view mammogram every two years, continuing to 69 if results are normal or benign.

A screening mammogram is reported as BI-RADS 4B. What should happen next?

Find the woman actively, give her a priority results appointment and order a biopsy; 4 means suspicious.

A 38-year-old has felt a lump for a month. Her friend says she is too young for screening. What is the right approach?

She is not being screened but investigated: any woman with a breast symptom needs a diagnostic workup now, usually ultrasound first at her age, and biopsy if indicated.

Why does a normal mammogram not exclude cancer in a woman with a palpable lump?

Mammography misses some cancers, especially in dense breasts, so a lump still needs ultrasound and, if in doubt, a biopsy.

A 28-year-old had chest radiotherapy for Hodgkin lymphoma at 16. Why does she not wait for the 50-to-69 mammogram schedule?

Chest radiation when young puts her at high risk, like a BRCA carrier: specialists plan yearly MRI plus mammography, usually from about eight years after the radiation and not before 25.

Add to my cards (5)

Elsewhere in DurgiPedia

Connections

← All of obstetrics and gynaecology

Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.

Sources: Resolución 3280 de 2018: lineamientos técnicos y operativos de la Ruta de Promoción y Mantenimiento de la Salud y de la Ruta Materno Perinatal (Ministerio de Salud y Protección Social de Colombia, 2018); Breast Cancer Screening in the Average-Risk Patient (StatPearls Publishing (NCBI Bookshelf), 2024); Screening Mammography in Breast Cancer Detection (StatPearls Publishing (NCBI Bookshelf), 2023); Breast cancer (fact sheet) (World Health Organization, 2026); Breast MRI in Clinical Practice (StatPearls (NCBI Bookshelf), 2023); BRCA Gene Changes: Cancer Risk and Genetic Testing (National Cancer Institute, 2024).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.